-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $8

Benzinga·07/01/2026 11:54:00
Listen to the news
BTIG analyst Thomas Shrader initiates coverage on Serina Therapeutics (AMEX:SER) with a Buy rating and announces Price Target of $8.